Cargando…
Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response
SIMPLE SUMMARY: Local treatment for oligometastatic hormone-naive prostate cancer has been shown to be effective in phase II trials. As for the efficacy of targeted therapy for oligometastatic castration-resistant prostate cancer, the results of the phase trial are not yet available, but the number...
Autores principales: | Yoshida, Soichiro, Takahara, Taro, Arita, Yuki, Toda, Kazuma, Kimura, Koichiro, Tanaka, Hajime, Yokoyama, Minato, Matsuoka, Yoh, Yoshimura, Ryoichi, Fujii, Yasuhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833545/ https://www.ncbi.nlm.nih.gov/pubmed/35158833 http://dx.doi.org/10.3390/cancers14030567 |
Ejemplares similares
-
Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy
por: Yoshida, Soichiro, et al.
Publicado: (2021) -
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
por: Yoshida, Soichiro, et al.
Publicado: (2023) -
Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma
por: Uchida, Yusuke, et al.
Publicado: (2022) -
Succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma
por: Yamaguchi, Yoshitomo, et al.
Publicado: (2022) -
Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti–PD-1 Treatment Efficacy in Urothelial Carcinoma
por: Fukushima, Hiroshi, et al.
Publicado: (2021)